Wilmington, DE · Founded 2021 · Privately Held (backing)
Operator of a medical device company intended to develop proprietary methods for subdermal photobiomodulation. Stimusil is based in Wilmington, DE and was founded in 2021. Its last reported valuation was $29.2 million in Aug 2023. It has raised $10.3 million across 3 recorded rounds; the latest was a $599,988 seed round in Dec 2024.
Last reported valuation
$29.2M
Oct 2026
Priced at
—
Total raised
$10.3M
Last round
Seed Round
Dec 2024
Team — not yet on record
No current team members for Stimusil are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stimusil with a free account
·Watch Stimusil: the Monday email on marks, rounds and moves
